Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Difei Yang
Recent news which mentions Difei Yang
Why This Bluebird Bio Analyst Sees Over 125% Upside Ahead
October 20, 2020
Tickers
BLUE
Tags
Initiation
Benzinga
Analyst Ratings
From
Benzinga
Mizuho Upgrades Audentes On Promising Gene Therapy Candidate
August 08, 2018
Tickers
BOLD
Tags
Benzinga
BOLD
Analyst Color
From
Benzinga
FibroGen Upgraded By Mizuho On Continued R&D Progress
May 15, 2018
Tickers
FGEN
Tags
Pamrevlumab
Biotech
Upgrades
From
Benzinga
Concert Pharma Drops On Patent Litigation Setback; Mizuho Downgrades
January 12, 2018
Tickers
CNCE
INCY
Tags
Analyst Ratings
General
Difei Yang
From
Benzinga
ZELTIQ Is The Leader In Non-Invasive Fat Reduction, Says Aegis
December 07, 2016
Tickers
TECH
ZLTQ
Tags
Analyst Color
Health Care
Initiation
From
Benzinga
Axsome Therapeutics: Teaching Old Drugs New Tricks
October 03, 2016
Tickers
AXSM
Tags
Analyst Color
Price Target
Brean Capital
From
Benzinga
Recro Pharma Offers A Non-Opioid Alternative For Pain Management; Brean Assumes With Buy Rating
October 03, 2016
Tickers
ALKS
REPH
Tags
Difei Yang
Brean
Analyst Ratings
From
Benzinga
Brean Assumes SCYNEXIS Shares At Buy, Sees 300% Upside
October 03, 2016
Tickers
SCYX
Tags
SCYX
Price Target
Brean Capital
From
Benzinga
Alder BioPharma Could Lead The Migraine Market; Brean Assumes With Buy Rating
September 30, 2016
Tickers
ALDR
AMGN
NEWS
Tags
Analyst Color
Price Target
Benzinga
From
Benzinga
Brean Likes Nektar Therapeutics' Upcoming Launches; Assumes Coverage At Buy
September 30, 2016
Tickers
AZN
BMY
NKTR
SHPG
Tags
AZN
Analyst Color
Price Target
From
Benzinga
Akebia Price Target Lowered, Still A Buy At Brean
September 29, 2016
Tickers
AKBA
Tags
Biotech
Brean Capital
Difei Yang
From
Benzinga
Brean Downgrades Pernix Therapeutics, Warns Of Unclear Path To Profitability
August 12, 2016
Tickers
PTX
Tags
Downgrades
Analyst Ratings
Benzinga
From
Benzinga
Galencia's Bid For Relypsa Is 'Reasonable,' Another Bidder 'Unlikely'
July 21, 2016
Tickers
RLYP
Tags
Price Target
Difei Yang
Brean Capital
From
Benzinga
Evoke Pharma Plunges 70%, Prompting Brean To Downgrade The Stock From Buy
July 18, 2016
Tickers
EVOK
Tags
EVOK
General
Analyst Ratings
From
Benzinga
June Data On Relypsa's Veltassa 'Very Encouraging'
July 12, 2016
Tickers
RLYP
Tags
Analyst Color
RLYP
Brean Capital
From
Benzinga
Brean Downgrades Revance Therapeutics Following RT-001 Fail
June 14, 2016
Tickers
RVNC
Tags
Downgrades
Health Care
News
From
Benzinga
Brean Reiterates Buy Rating On Revance Ahead Of Upcoming Phase 3 Read-Out
May 24, 2016
Tickers
RVNC
Tags
Brean Capital
Difei Yang
Biotech
From
Benzinga
Brean Thinks Relypsa's Veltassa Sales Were 'Solid, But Not Impressive'
May 17, 2016
Tickers
RLYP
Tags
RLYP
Brean Capital
Difei Yang
From
Benzinga
Brean's Yang: Relypsa Monthly Prescription Data Met Expectations, A Takeout Still 'Probable'
April 15, 2016
Tickers
RLYP
Tags
Analyst Ratings
General
Benzinga
From
Benzinga
Brean Initiates Relypsa With Buy Rating, $26 Target
March 29, 2016
Tickers
RLYP
Tags
Kayexalate
Hyperkalemia
Biotech
From
Benzinga
Brean: Pernix Deal Could Occur Soon, Stock Worth $8
February 09, 2016
Tickers
PTX
Tags
Health Care
Benzinga
Reiteration
From
Benzinga
Brean Reiterates Buy On Horizon Pharma, Likes Crealta Deal
December 14, 2015
Tickers
HZNP
Tags
Crealta Holdings LLC
General
Analyst Ratings
From
Benzinga
Premium No Longer Deserved? Why Brean's Difei Yang Is Downgrading Horizon Pharma
September 22, 2015
Tickers
HZNP
Tags
Brean
Analyst Color
Difei Yang
From
Benzinga
Brean Capital Initiates Coverage On Osiris Therapeutics
December 29, 2014
Tickers
OSIR
Tags
Analyst Ratings
Initiation
Benzinga
From
Benzinga
Brean Capital Initiates Coverage On Zogenix
December 29, 2014
Tickers
ZGNX
Tags
Benzinga
Initiation
Analyst Ratings
From
Benzinga
Zohydro Gains Massachusetts Approval, Acts As Minor Catalyst For Zogenix
August 05, 2014
Tickers
ZGNX
Tags
Benzinga
News
R/F/ Lafferty & Co
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.